Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Island biogeography effects on microbial evolution may contribute to Crohn's disease.

Johnson MA, Winquist RJ.

Biochem Pharmacol. 2011 Dec 15;82(12):1801-6. doi: 10.1016/j.bcp.2011.07.088. Epub 2011 Jul 27.

PMID:
21820421
3.

Adherent-invasive Escherichia coli and Crohn's disease.

Barnich N, Darfeuille-Michaud A.

Curr Opin Gastroenterol. 2007 Jan;23(1):16-20. Review.

PMID:
17133079
5.

Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.

Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners CP, Darfeuille-Michaud A.

J Exp Med. 2009 Sep 28;206(10):2179-89. doi: 10.1084/jem.20090741. Epub 2009 Sep 8.

6.

Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease.

Martinez-Medina M, Aldeguer X, Lopez-Siles M, González-Huix F, López-Oliu C, Dahbi G, Blanco JE, Blanco J, Garcia-Gil LJ, Darfeuille-Michaud A.

Inflamm Bowel Dis. 2009 Jun;15(6):872-82. doi: 10.1002/ibd.20860.

PMID:
19235912
7.

Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II).

Chandran P, Satthaporn S, Robins A, Eremin O.

Surgeon. 2003 Jun;1(3):125-36. Review.

PMID:
15570747
8.
9.
10.

The gut microbiota in inflammatory bowel disease.

Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S.

Curr Pharm Des. 2009;15(13):1528-36. Review.

PMID:
19442170
11.

Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells.

Eaves-Pyles T, Allen CA, Taormina J, Swidsinski A, Tutt CB, Jezek GE, Islas-Islas M, Torres AG.

Int J Med Microbiol. 2008 Jul;298(5-6):397-409. Epub 2007 Sep 27.

PMID:
17900983
12.

[Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].

Belkahla N, Maamouri N, Ouerghi H, Ben Ammar A.

Tunis Med. 2005 Mar;83(3):132-6. Review. French.

PMID:
15929439
13.

Adaptation of bacteria to the intestinal niche: probiotics and gut disorder.

Dunne C.

Inflamm Bowel Dis. 2001 May;7(2):136-45. Review.

PMID:
11383587
14.

[Intestinal flora and Crohn's disease].

Desreumaux P, Colombel JF.

Ann Pharm Fr. 2003 Jul;61(4):276-81. Review. French.

PMID:
12843962
15.

Resident bacterial flora and immune system.

Biancone L, Monteleone I, Del Vecchio Blanco G, Vavassori P, Pallone F.

Dig Liver Dis. 2002 Sep;34 Suppl 2:S37-43. Review.

PMID:
12408438
16.
17.

Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer.

Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM.

Gastroenterology. 2004 Jul;127(1):80-93.

PMID:
15236175
18.

Prebiotic effects: metabolic and health benefits.

Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A.

Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363. Review.

PMID:
20920376
19.

Clinical usefulness of probiotics in inflammatory bowel diseases.

Mach T.

J Physiol Pharmacol. 2006 Nov;57 Suppl 9:23-33. Review.

PMID:
17242485
20.

Probiotics, prebiotics, and synbiotics.

de Vrese M, Schrezenmeir J.

Adv Biochem Eng Biotechnol. 2008;111:1-66. doi: 10.1007/10_2008_097. Review.

PMID:
18461293

Supplemental Content

Support Center